BRIEFING
Ibandronate Sodium Tablets. Because there is no existing USP monograph for this drug product, a new monograph based on validated methods of analysis is proposed. The proposal for this drug product which appeared in PF 46(4) [July–Aug. 2020] was canceled and is replaced with a new proposal.
-
The liquid chromatographic procedures used in the Assay and Dissolution test are validated using the Inertsil C8-3 brand of column with L7 packing. The typical retention time for ibandronic acid is about 8 min.
-
The liquid chromatographic procedure used in the Organic Impurities test is validated using the Inertsil C8-3 brand of column with L7 packing. The typical retention time for ibandronic acid is about 10 min.
(SM3: R. Fales)
Case ID—SUB-770